1071TiP Phase I study of the investigational CD228 x 4-1BB costimulatory antibody anticalin bispecific SGN-BB228 (PF-08046049) in advanced melanoma and other solid tumors. - Dummer, R.; Daud, A.; Eigentler, T.K.; Evans, T.R.J.; Henry, J.; Hodi, F.S.; Miller, W.H.; Robert, C.; Saibil, S.; Tachiki, L.; Nayeri, M.; Xing, B.; et al. (Annals of Oncology, 2024)